André Valencio Siqueira

Mr. André Valencio Siqueira

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
ÁRÁghata Cardoso da Silva Ribeiro
Ághata Cardoso da Silva Ribeiro
YCYohanna Carvalho dos Santos Aoun Chikhani
Yohanna Carvalho dos Santos Aoun Chikhani
TVTiago Barcelos Valiatti
Tiago Barcelos Valiatti
ASAndré Valencio Siqueira
André Valencio Siqueira
MKMariana Neri Lucas Kurihara
Mariana Neri Lucas Kurihara
AGAna Cristina Gales
Ana Cristina Gales
Fosfomycin disodium is a potential therapeutic option to manage difficult-to-treat infections, especially when combined with other antimicrobials. In this study, we evaluated the activity of fosfomycin in combination with meropenem or polymyxin B against contemporaneous KPC-2-producing K. pneumoniae clinical isolates (KPC-KPN). Synergistic activity was assessed by checkerboard (CKA) and time–kill (TKA) assays. TKA was performed using serum peak and trough concentrations. The activity of these combinations was also assessed in the Galleria mellonella model. Biofilm disruption was assessed by the microtiter plate technique. CKA resulted in an 8- to 2048-fold decrease in meropenem MIC, restoring meropenem activity for 82.4% of the isolates when combined with fosfomycin. For the fosfomycin + polymyxin B combination, a 2- to 128-fold reduction in polymyxin B MIC was achieved, restoring polymyxin B activity for 47% of the isolates. TKA resulted in the synergism of fosfomycin + meropenem (3.0–6.7 log10 CFU/mL decrease) and fosfomycin + polymyxin B (6.0–6.2 log10 CFU/mL decrease) at peak concentrations. All larvae treated with fosfomycin + meropenem survived. Larvae survival rate was higher with fosfomycin monotherapy (95%) than that observed for fosfomycin + polymyxin B (75%) (p-value < 0.0001). Finally, a higher biofilm disruption was observed under exposure to fosfomycin + polymyxin B (2.4–3.4-fold reduction). In summary, we observed a synergistic effect of fosfomycin + meropenem and fosfomycin + polymyxin B combinations, in vitro and in vivo, against KPC-KPN, as well as biofilm disruption.

18 April 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
ASAndré Valencio Siqueira
André Valencio Siqueira
MSMíriam Aparecida da SILVA
Míriam Aparecida da SILVA
FSFernanda Fernandes dos Santos
Fernanda Fernandes dos Santos
JPJuliana POLATTO
Juliana POLATTO
MMMarcelo F.M. Marcondes
Marcelo F.M. Marcondes
AGAna Cristina Gales
Ana Cristina Gales
The detection of KPC-type carbapenemases is necessary for guiding appropriate antibiotic therapy and the implementation of antimicrobial stewardship and infection control measures. Currently, few tests are capable of differentiating carbapenemase types, restricting the lab reports to their presence or not. The aim of this work was to raise antibodies and develop an ELISA test to detect KPC-2 and its D179 mutants. The ELISA-KPC test was designed using rabbit and mouse polyclonal antibodies. Four different protocols were tested to select the bacterial inoculum with the highest sensitivity and specificity rates. The standardisation procedure was performed using 109 previously characterised clinical isolates, showing 100% of sensitivity and 89% of specificity. The ELISA-KPC detected all isolates producing carbapenemases, including KPC variants displaying the ESBL phenotype such as KPC-33 and -66.

11 April 2024 in Chemosphere
Verified
Journal Article
Closed access
FSFernanda Fernandes dos Santos
Fernanda Fernandes dos Santos
TVTiago Barcelos Valiatti
Tiago Barcelos Valiatti
ASAndré Valencio Siqueira
André Valencio Siqueira
ÁRÁghata Cardoso da Silva Ribeiro
Ághata Cardoso da Silva Ribeiro
AOAna Paula Streling de Oliveira
Ana Paula Streling de Oliveira
AGAna Cristina Gales
Ana Cristina Gales

7 June 2024 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
JSJuliana Thalita P. Silva
Juliana Thalita P. Silva
FSFernanda Fernandes dos Santos
Fernanda Fernandes dos Santos
TVTiago B. Valiatti
Tiago B. Valiatti
ASAndré Valencio Siqueira
André Valencio Siqueira
ÁRÁghata Cardoso da Silva Ribeiro
Ághata Cardoso da Silva Ribeiro
AGAna Cristina Gales
Ana Cristina Gales
Despite the increasing reports of blaNDM in Enterobacterales in Brazil, comprehensive whole genome sequencing (WGS) data remain scarce. To address this knowledge gap, our study focuses on the characterization of the genome of an New Delhi Metallo-β-lactamase (NDM)-1-producing Klebsiella quasipneumoniae subsp. quasipneumoniae (KQPN) clinical strain isolated in Brazil. The antimicrobial susceptibility profile of the A-73.113 strain was performed by agar dilution or broth microdilution following the Brazilian Antimicrobial Susceptibility Testing Committee/European Committee on Antimicrobial Susceptibility Testing recommendations. WGS was performed using the Illumina® NextSeq platform and the generated reads were assembled using the SPAdes software. The sequences obtained were submitted to the bioinformatics pipelines to determine the sequence type, resistome, plasmidome, and virulome. The A-73.113 strain was identified as KQPN and was susceptible to polymyxins (MICs, ≤0.25 µg/mL), tigecycline (MIC, 0.5 µg/mL), ciprofloxacin (MIC, 0.5 µg/mL), and levofloxacin (MIC, 1 µg/mL). WGS analysis revealed the presence of genes conferring resistance to β-lactams (blaNDM-1, blaCTX-M-15, blaOXA-9, blaOKP-A-5, blaTEM-1), aminoglycosides [aph(3')-VI, aadA1, aac(6')-Ib], and fluoroquinolones (oqxAB, qnrS1, aac(6')-Ib-cr]. Additionally, the presence of the plasmid replicons Col(pHAD28), IncFIA(HI1), IncFIB(K) (pCAV1099-114), IncFIB(pQil), and IncFII(K), as well as virulence-encoding genes fimABCDEFGHIK (type 1 fimbria), pilW (type IV pili), iutA (aerobactin), entABCDEFS/fepABCDG/fes (Ent siderophores), iroE (salmochelin), and allABCDRS (allantoin utilization) was verified. Furthermore, we found that the A-73.113 strain belongs to ST1040. Here we report the genomic characteristics of an NDM-1-producing KQPN ST1040 strain isolated from blood cultures in Brazil. These data will enhance our comprehension of how this species contributes to the acquisition and dissemination of blaNDM-1 in Brazilian nosocomial settings.

9 September 2022 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
Felipe Alberto LeiFelipe Alberto Lei
Felipe Alberto Lei
CNCarolina Nodari
Carolina Nodari
AOAna Paula Streling de Oliveira
Ana Paula Streling de Oliveira
FBFrancisco Ozório Bessa-Neto
Francisco Ozório Bessa-Neto
ASAndré Valencio Siqueira
André Valencio Siqueira
AGAna Cristina Gales
Ana Cristina Gales